Clinical Trial: Patients With a Single, Small (2 cm or Less) Cancer Nodule in the Thyroid Gland Will be Offered Active Surveillance Initially for 5 Years. In Case of Cancer Growth or Changes in Ultrasonographic Appearance, Further Treatment Will be Offered.

U.S., Sept. 17 -- ClinicalTrials.gov registry received information related to the study (NCT07822217) titled 'Patients With a Single, Small (2 cm or Less) Cancer Nodule in the Thyroid Gland Will be Offered Active Surveillance Initially for 5 Years. In Case of Cancer Growth or Changes in Ultrasonographic Appearance, Further Treatment Will be Offered.' on Sept. 10.

Brief Summary: Patients with a single, small (less than 2 cm) cancer nodule in the thyroid gland will be offered active surveillance initially for 5 years. In case of cancer growth or changes in ultrasonographic appearance, further treatment will be offered.

Study Start Date: March 01

Study Type: OBSERVATIONAL

Condition: Thyroid Cancer Active Surveillance

Recruitment Status: ...